However, the fraction of annexin-V-positive cells was approximately 10% in the TP53mut THP-1 cells and did not increase with a higher concentration of venetoclax (Figure 1b), suggesting that TP53 mutation is one of the molecular abnormalities associated with venetoclax resistance in AML cells. This evidence concerns the gene ANXA5 and acute myeloid leukemia.